201. Transplant trends in Mexico during the COVID-19 pandemic: Disparities within healthcare sectors
- Author
-
Luis Navarro-Vargas, Fernando Ramirez Del Val, Armando Torres-Gomez, Maximiliano Servin-Rojas, Ignacio García-Juárez, and Antonio Olivas-Martinez
- Subjects
Coronavirus disease 2019 (COVID-19) ,MEDLINE ,Health Care Sector ,Brief Communication ,insurance ‐ public ,Health care ,Pandemic ,medicine ,Humans ,Immunology and Allergy ,Pharmacology (medical) ,kidney transplantation / nephrology ,insurance ‐ private ,Healthcare Disparities ,Mexico ,Pandemics ,Kidney transplantation ,disparities ,Transplantation ,SARS-CoV-2 ,business.industry ,Nationwide database ,COVID-19 ,Public institution ,liver transplantation / hepatology ,health services and outcomes research ,medicine.disease ,ethics and public policy ,corneal transplantation / ophthalmology ,registry/registry analysis ,Brief Communications ,business ,Demography - Abstract
Healthcare systems worldwide were challenged during the COVID‐19 pandemic. In Mexico, the public hospitals that perform most transplants were adapted to provide care for COVID‐19 patients. Using a nationwide database, we describe the first report of the impact of COVID‐19 and related transplantation healthcare policies in a middle‐income country by comparing statistics before and during the pandemic (pre‐COVID: March 2019–February 2020 vs. COVID era: March 2020–February 2021) and by type of institution (public vs. private). The global reduction in transplantation was higher in public institutions compared with private institutions, 89% versus 62%, respectively, p
- Published
- 2021